A Decade of Ovarian Cancer in Indonesia: Epidemiology and Survival Analysis from 2010 to 2020
Journal of Clinical Medicine · 03.03.2025 · 14 (5) · 1692
DOI: 10.3390/jcm14051692 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Clinical Medicine, online erschienen am 03.03.2025. Verfasst von Primariadewi Rustamadji und 12 weiteren Autor:innen. Beteiligte Einrichtung: Department of Anatomic Pathology, Faculty of Medicine, Universitas Indonesia, Dr. Cipto Mangunkusumo National Hospital, Jakarta 10430, Indonesia. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 27 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background
Ovarian cancer is a major global health issue, ranking among the foremost causes of cancer-related death in women. Despite its prevalence, epidemiology data and survival analysis pertinent to Indonesia are few. This study seeks to address the information gap by analyzing the demographic characteristics, clinical aspects, and survival outcomes of ovarian cancer patients in Indonesia from 2010 to 2020.
Methods
This observational study utilized data from the Indonesian Cancer Database. This study included patients with a confirmed diagnosis of ovarian cancer. Data collected included age, parity, overall survival, geographic distribution, ethnicity, occupation, FIGO stage, tumor types, category, and degree of differentiation. Descriptive statistics were used to summarize the data, and Kaplan–Meier survival curves were employed to estimate survival probabilities over time.
Results
The study cohort comprised 1065 patients with ovarian cancer. The cohort’s mean age was 52.41 (12.56) years, with 45.35% of patients residing in Jakarta. A majority were unemployed (75.77%) and of Javanese ethnicity (61.88%). Serous carcinoma (68.26%) was the most prevalent tumor types, while a high percentage of unknown FIGO stages (66.95%) limited staging data. The survival median time varied, with significant survival variation observed across tumor types, degrees of differentiation, and FIGO stages. Patients with serous carcinoma showed aggressive behavior with a median survival of 1 month, whereas clear cell carcinoma had a median survival of 9 months.
Conclusions
This study highlights the need for improved early detection and equitable access to care to enhance survival outcomes for ovarian cancer patients in Indonesia.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Anatomic Pathology, Faculty of Medicine, Universitas Indonesia, Dr. Cipto Mangunkusumo National Hospital, Jakarta 10430, Indonesia.
- Intensive Care Unit, University of Indonesia Hospital, Depok 16424, Indonesia.
- Service Department, Risetku, Jakarta 12820, Indonesia.
- Department Obstetrics and Gynecology, Faculty of Medicine, Universitas Indonesia, Dr. Cipto Mangunkusumo National Hospital, Jakarta 10430, Indonesia.
- Faculty of Public Health, Universitas Indonesia, Depok 12345, Indonesia.
ORCID-Profile: Elvan Wiyarta, Gatot Purwoto, Hariyono Winarto
Zitieren
APA
Rustamadji, P., Wiyarta, E., Nuryanto, K. H., Anggraeni, T. D., Kusuma, F., Purwoto, G., Winarto, H., Heliyanti, T., Tjahjadi, H., Hayati, A., Sartika, R. A. D., Prasetyo, S., & Andrijono, A. (2025). A Decade of Ovarian Cancer in Indonesia: Epidemiology and Survival Analysis from 2010 to 2020. Journal of Clinical Medicine, 14(5), 1692. https://doi.org/10.3390/jcm14051692
Vancouver
Rustamadji P, Wiyarta E, Nuryanto KH, Anggraeni TD, Kusuma F, Purwoto G, et al. A Decade of Ovarian Cancer in Indonesia: Epidemiology and Survival Analysis from 2010 to 2020. Journal of Clinical Medicine. 2025;14(5):1692. doi:10.3390/jcm14051692
BibTeX
@article{Rustamadji2025,
author = {Rustamadji, Primariadewi and Wiyarta, Elvan and Nuryanto, Kartiwa Hadi and Anggraeni, Tricia Dewi and Kusuma, Fitriyadi and Purwoto, Gatot and Winarto, Hariyono and Heliyanti, Tantri and Tjahjadi, Hartono and Hayati, Amal and Sartika, Ratu Ayu Dewi and Prasetyo, Sabarinah and Andrijono, Andrijono},
title = {A Decade of Ovarian Cancer in Indonesia: Epidemiology and Survival Analysis from 2010 to 2020},
journal = {Journal of Clinical Medicine},
year = {2025},
volume = {14},
number = {5},
pages = {1692},
doi = {10.3390/jcm14051692}
}
EUVIMED